ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.002,02
-1,43%
S&P 500
5.431,66
-0,04%
Dow Jones
38.589,49
-0,15%
Euro vs US Dollar
1,07036
-0,32%
Bitcoin
65.507,64
-1,87%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NYSE
  6. Aurora Cannabis Inc (ACB)

  7. Aurora Cannabis Inc (ACB) News

ACB

Aurora Cannabis (ACB)

Aurora Cannabis Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NYSE:ACB
DatumZeitQuelleÜberschriftSymbolFirma
07/06/202413h00PR Newswire (Canada)Aurora Cannabis to Host Fourth Quarter and Fiscal Year 2024 Investor Conference Call and File Related Year End InformationNYSE:ACBAurora Cannabis Inc
07/06/202413h00PR Newswire (US)Aurora Cannabis to Host Fourth Quarter and Fiscal Year 2024 Investor Conference Call and File Related Year End InformationNYSE:ACBAurora Cannabis Inc
05/06/202413h00PR Newswire (US)Aurora Unveils Premium Resin Cartridges in AustraliaNYSE:ACBAurora Cannabis Inc
05/06/202413h00PR Newswire (Canada)Aurora Unveils Premium Resin Cartridges in AustraliaNYSE:ACBAurora Cannabis Inc
15/05/202413h00PR Newswire (Canada)Aurora Cannabis Announces Appointment of New DirectorNYSE:ACBAurora Cannabis Inc
15/05/202413h00PR Newswire (US)Aurora Cannabis Announces Appointment of New DirectorNYSE:ACBAurora Cannabis Inc
08/05/202413h15PR Newswire (Canada)Aurora Marks First Shipment of Medical Cannabis to the New Zealand MarketNYSE:ACBAurora Cannabis Inc
08/05/202413h15PR Newswire (US)Aurora Marks First Shipment of Medical Cannabis to the New Zealand MarketNYSE:ACBAurora Cannabis Inc
30/04/202413h15PR Newswire (Canada)Aurora Improves Offerings in Australia with New Range of Premium Dried Flower ProductsNYSE:ACBAurora Cannabis Inc
30/04/202413h15PR Newswire (US)Aurora Improves Offerings in Australia with New Range of Premium Dried Flower ProductsNYSE:ACBAurora Cannabis Inc
01/04/202413h00PR Newswire (US)Aurora Cannabis Commends Germany's Landmark Legalization AchievementNYSE:ACBAurora Cannabis Inc
01/04/202413h00PR Newswire (Canada)Aurora Cannabis Commends Germany's Landmark Legalization AchievementNYSE:ACBAurora Cannabis Inc
04/03/202415h42PR Newswire (Canada)Aurora Introduces Medical Cannabis Pastilles for Patient Relief in AustraliaNYSE:ACBAurora Cannabis Inc
04/03/202415h42PR Newswire (US)Aurora Introduces Medical Cannabis Pastilles for Patient Relief in AustraliaNYSE:ACBAurora Cannabis Inc
29/02/202423h00PR Newswire (US)Aurora Completes Final Repayment of Convertible Senior Notes Representing ~$465 Million in Total Repayments Since 2021; Cannabis Operations Are Now Debt Free[1]NYSE:ACBAurora Cannabis Inc
29/02/202423h00PR Newswire (Canada)Aurora Completes Final Repayment of Convertible Senior Notes Representing ~$465 Million in Total Repayments Since 2021; Cannabis Operations Are Now Debt Free[1]NYSE:ACBAurora Cannabis Inc
28/02/202413h13PR Newswire (US)Aurora Partners with Script Assist to Provide Better Access to UK Medical CannabisNYSE:ACBAurora Cannabis Inc
28/02/202413h11PR Newswire (Canada)Aurora Partners with Script Assist to Provide Better Access to UK Medical CannabisNYSE:ACBAurora Cannabis Inc
28/02/202413h11PR Newswire (US)Aurora Partners with Script Assist to Provide Better Access to UK Medical CannabisNYSE:ACBAurora Cannabis Inc
20/02/202413h00PR Newswire (US)Aurora Cannabis Announces CFO Transition and Completion of Previously Announced Share ConsolidationNYSE:ACBAurora Cannabis Inc
20/02/202413h00PR Newswire (Canada)Aurora Cannabis Announces CFO Transition and Completion of Previously Announced Share ConsolidationNYSE:ACBAurora Cannabis Inc
08/02/202413h00PR Newswire (US)Aurora Cannabis Announces Fiscal 2024 Third Quarter Results; Generates Record Adjusted EBITDA of $4.3 MillionNYSE:ACBAurora Cannabis Inc
08/02/202413h00PR Newswire (Canada)Aurora Cannabis Announces Fiscal 2024 Third Quarter Results; Generates Record Adjusted EBITDA of $4.3 MillionNYSE:ACBAurora Cannabis Inc
08/02/202412h45PR Newswire (US)Aurora Cannabis Acquires MedReleaf AustraliaNYSE:ACBAurora Cannabis Inc
08/02/202412h45PR Newswire (Canada)Aurora Cannabis Acquires MedReleaf AustraliaNYSE:ACBAurora Cannabis Inc
31/01/202413h00PR Newswire (Canada)Aurora Cannabis Provides Business Update and Announces Date of Third Quarter Fiscal Year 2024 Investor Conference CallNYSE:ACBAurora Cannabis Inc
31/01/202413h00PR Newswire (US)Aurora Cannabis Provides Business Update and Announces Date of Third Quarter Fiscal Year 2024 Investor Conference CallNYSE:ACBAurora Cannabis Inc
24/01/202413h55PR Newswire (Canada)Aurora Unveils Innovative Cannabis-Infused Ready-to-Drink Beverage in Latest Medical Product LaunchNYSE:ACBAurora Cannabis Inc
24/01/202413h55PR Newswire (US)Aurora Unveils Innovative Cannabis-Infused Ready-to-Drink Beverage in Latest Medical Product LaunchNYSE:ACBAurora Cannabis Inc
09/11/202322h15PR Newswire (US)Aurora Cannabis Announces Fiscal 2024 Second Quarter Results and Delivers Record Positive Adjusted EBITDANYSE:ACBAurora Cannabis Inc
 Showing the most relevant articles for your search:NYSE:ACB

Kürzlich von Ihnen besucht

UPBT
AQTBTC
Alpha Quark Token
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten